WeVote
Log In

Bill

Bill

HB 5260

Relating generally to medical cannabis

2026 Regular Session Introduced by Michael Amos and 10 co-sponsors

West Virginia medical cannabis bill under review; likely establishes patient access, regulatory framework, or program implementation parameters for the state.

To Health and Human Resources
#health
0
WeVote Research Nonpartisan
Bill Summary · HB 5260

Legislative bill overview

HB 5260 is a West Virginia bill that addresses medical cannabis policy, though the specific provisions are not detailed in the available information. The bill was introduced in February 2026 and is currently under review by the House Health and Human Resources Committee. Based on the committee routing, it likely concerns regulatory frameworks, patient access, or implementation of medical cannabis programs.

Why is this important

Medical cannabis legislation directly affects patient access to alternative treatments, healthcare provider guidance, and state regulatory infrastructure. West Virginia's approach to this issue could influence treatment options for residents with qualifying conditions and establish precedents for how the state manages controlled substances in healthcare contexts.

Potential points of contention

  • Qualifying conditions and patient eligibility – Disagreement may exist over which medical conditions warrant access and how strictly eligibility criteria should be defined
  • Regulatory oversight and licensing – Disputes could arise regarding which agencies oversee cultivation, distribution, and quality control, and what licensing requirements apply
  • Federal-state legal conflict – Tension between federal prohibition and state legalization creates compliance and banking challenges that require careful legislative navigation

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.